Delivery Order SPE2DE24D0013-SPE2D626F3496

Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,925 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 28, 2025. The contract, designated XPRS-COV2-10, represents a delivery order for diagnostic reagents and test kits—specifically XPRS-COV2-10 cartridges for respiratory pathogen detection on the GeneXpert diagnostic platform. This award carries no set-aside designation and is performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is part of Cepheid's larger indefinite delivery contract portfolio with the Department of Veterans Affairs, which includes substantial prime contracts valued at $6.7 million and $32.8 million across multiple Veterans Integrated Service Networks through 2030.

This contract award reflects the Defense Logistics Agency's continued reliance on Cepheid as a primary federal supplier of molecular diagnostic solutions across the federal healthcare system. Cepheid has established itself as a critical vendor for COVID-19, influenza, and respiratory syncytial virus testing capabilities, serving multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The firm fixed-price structure and modest order value of this delivery order are consistent with Cepheid's pattern of providing responsive, demand-driven procurement support to federal medical supply chain operations.